ES2508165T3 - Lactoferrina y sustancia blanca - Google Patents
Lactoferrina y sustancia blanca Download PDFInfo
- Publication number
- ES2508165T3 ES2508165T3 ES11189879.7T ES11189879T ES2508165T3 ES 2508165 T3 ES2508165 T3 ES 2508165T3 ES 11189879 T ES11189879 T ES 11189879T ES 2508165 T3 ES2508165 T3 ES 2508165T3
- Authority
- ES
- Spain
- Prior art keywords
- lactoferrin
- white matter
- development
- white substance
- white
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000010445 Lactoferrin Human genes 0.000 title abstract 2
- 108010063045 Lactoferrin Proteins 0.000 title abstract 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title abstract 2
- 229940078795 lactoferrin Drugs 0.000 title abstract 2
- 235000021242 lactoferrin Nutrition 0.000 title abstract 2
- 210000004885 white matter Anatomy 0.000 title 1
- 239000000126 substance Substances 0.000 abstract 2
- 230000003111 delayed effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Pediatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Composición que comprende lactoferrina para promover el desarrollo de la sustancia blanca, para tratar o prevenir el desarrollo retrasado de la sustancia blanca y o una pérdida de la misma.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11189879.7A EP2594282B1 (en) | 2011-11-21 | 2011-11-21 | Lactoferrin and the white matter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2508165T3 true ES2508165T3 (es) | 2014-10-16 |
Family
ID=47263282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11189879.7T Active ES2508165T3 (es) | 2011-11-21 | 2011-11-21 | Lactoferrina y sustancia blanca |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20140288004A1 (es) |
| EP (2) | EP2594282B1 (es) |
| JP (1) | JP2015500203A (es) |
| CN (1) | CN103957928B (es) |
| ES (1) | ES2508165T3 (es) |
| PL (1) | PL2594282T3 (es) |
| PT (1) | PT2594282E (es) |
| WO (1) | WO2013076101A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10709770B2 (en) | 2013-07-31 | 2020-07-14 | Mead Johnson Nutrition Company | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof |
| US9609888B2 (en) * | 2013-07-31 | 2017-04-04 | Mead Johnson Nutrition Company | Nutritional compositions containing synergistic combination and uses thereof |
| MX2016001225A (es) * | 2013-09-02 | 2016-05-24 | Nestec Sa | Lactoferrina y memoria y velocidad de aprendizaje en niños. |
| CN105492018A (zh) * | 2013-09-02 | 2016-04-13 | 雀巢产品技术援助有限公司 | 乳铁蛋白和儿童的记忆和学习速度 |
| US10582714B2 (en) | 2015-07-10 | 2020-03-10 | Mead Johnson Nutrition Company | Nutritional compositions and methods for promoting cognitive development |
| US10617701B2 (en) | 2015-07-10 | 2020-04-14 | Mead Johnson Nutrition Company | Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid |
| CN111839515B (zh) * | 2019-04-26 | 2024-03-08 | 西门子医疗系统有限公司 | 利用磁共振成像的胎儿胼胝体体积的测量方法及磁共振成像装置 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU85479A1 (fr) * | 1984-07-25 | 1986-02-12 | Oleofina Sa | Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer |
| JP2006523445A (ja) * | 2003-04-15 | 2006-10-19 | デーエスエム アイピー アセッツ ベー． ヴェー． | 飼料サプリメント組成物 |
| EP2032170B1 (en) * | 2006-06-14 | 2012-11-28 | N.V. Nutricia | Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof |
| US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
| EP2251030A1 (en) * | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
| EP2251029A1 (en) * | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and gut neuronal health in adults and/or elderly |
| EP2251032A1 (en) * | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and protection in adults |
| EP2251031A1 (en) * | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and neuronal health and development in the infant gut |
-
2011
- 2011-11-21 ES ES11189879.7T patent/ES2508165T3/es active Active
- 2011-11-21 PL PL11189879T patent/PL2594282T3/pl unknown
- 2011-11-21 PT PT111898797T patent/PT2594282E/pt unknown
- 2011-11-21 EP EP11189879.7A patent/EP2594282B1/en active Active
-
2012
- 2012-11-20 EP EP12794239.9A patent/EP2782591A1/en not_active Withdrawn
- 2012-11-20 WO PCT/EP2012/073138 patent/WO2013076101A1/en active Application Filing
- 2012-11-20 CN CN201280057156.2A patent/CN103957928B/zh active Active
- 2012-11-20 US US14/359,477 patent/US20140288004A1/en not_active Abandoned
- 2012-11-20 JP JP2014541711A patent/JP2015500203A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015500203A (ja) | 2015-01-05 |
| US20140288004A1 (en) | 2014-09-25 |
| PL2594282T3 (pl) | 2015-01-30 |
| EP2594282B1 (en) | 2014-07-23 |
| EP2782591A1 (en) | 2014-10-01 |
| CN103957928B (zh) | 2016-10-05 |
| WO2013076101A1 (en) | 2013-05-30 |
| PT2594282E (pt) | 2014-09-26 |
| EP2594282A1 (en) | 2013-05-22 |
| CN103957928A (zh) | 2014-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2508165T3 (es) | Lactoferrina y sustancia blanca | |
| ES2582284T3 (es) | Composición que comprende microbiota intestinal humana anaeróbicamente cultivada | |
| ES2496092T3 (es) | El uso de amisulprida para tratar náuseas y vómitos posoperatorios | |
| ES2502472T3 (es) | Composición adhesiva para su uso en un inmunosensor | |
| ES2661582T3 (es) | Efecto antiinflamatorio de la celulosa microfibrilada | |
| ES2488407T3 (es) | Preparación farmacéutica que contiene lipasa de origen bacteriano | |
| MX2014000518A (es) | Inhibidores de la tirosina quinasa de bruton. | |
| CO6602146A2 (es) | Uso combinado de proteínas cryda y cry1fa para el manejo de la resistencia de los insectos | |
| ES2616049T3 (es) | Mejora de la función renal con composiciones que contienen quercetina | |
| CO6531429A2 (es) | Inhibidores de la tirosina quinasa de bruton | |
| ES2637421T3 (es) | Composiciones tópicas que comprenden variantes de pliegue-OB | |
| ES2596248T3 (es) | N-Carbamoilputrescina para mejorar la síntesis de proteínas musculares | |
| CL2011001232A1 (es) | Combinacion farmaceutica que comprende un anticuerpo que reconoce especificamente la cd38 y al menos citarabina; y su uso para el tratamiento de cancer | |
| EA201791850A1 (ru) | Борсодержащие малые молекулы | |
| CL2017001632A1 (es) | Manufactura de proteína. | |
| CL2014002348A1 (es) | Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado. | |
| EA201200484A1 (ru) | Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином | |
| CR20170425A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| ES2613400T3 (es) | Método para mejorar la fagocitosis de células que exponen fosfatidilserina | |
| ES2616017T3 (es) | Composiciones que contienen sulfato de condroitina, nattocinasa y compuestos de sulfhidrilo para su uso en el tratamiento de inflamación | |
| CL2015002253A1 (es) | Composiciones farmacéuticas para el tratamiento de la helicobacter pylori. | |
| AR086240A1 (es) | Composiciones que comprenden un antimetabolito de glucosa, bha y/o bht | |
| CR20150310A (es) | Solución para preservar conductos vasculares | |
| UY33938A (es) | Artículo para fumar que incluye dos o más segmentos de filtro | |
| AR082215A1 (es) | Composicion farmaceutica agradable al paladar |